Is TuHURA Biosciences Stock a Good Investment?
TuHURA Biosciences Investment Advice | HURA |
- Examine TuHURA Biosciences' financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research TuHURA Biosciences' leadership team and their track record. Good management can help TuHURA Biosciences navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Pharmaceutical Products space and any emerging trends that could impact TuHURA Biosciences' business and its evolving consumer preferences.
- Compare TuHURA Biosciences' performance and market position to its competitors. Analyze how TuHURA Biosciences is positioned in terms of product offerings, innovation, and market share.
- Check if TuHURA Biosciences pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about TuHURA Biosciences' stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in TuHURA Biosciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if TuHURA Biosciences is a good investment.
Sell | Buy |
Sell
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine TuHURA Biosciences Stock
Researching TuHURA Biosciences' stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years. TuHURA Biosciences had 1:35 split on the 18th of October 2024.
To determine if TuHURA Biosciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding TuHURA Biosciences' research are outlined below:
| TuHURA Biosciences generated a negative expected return over the last 90 days | |
| TuHURA Biosciences has high historical volatility and very poor performance | |
| TuHURA Biosciences has a very high chance of going through financial distress in the upcoming years | |
| TuHURA Biosciences was previously known as KTRA Old and was traded on NASDAQ Exchange under the symbol KTRA. | |
| Net Loss for the year was (29.32 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| TuHURA Biosciences generates negative cash flow from operations | |
| TuHURA Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: TuHURA Biosciences Announces Acquisition of Kineta, Inc. - MSN |
TuHURA Biosciences Quarterly Cash And Short Term Investments |
|
Earnings surprises can significantly impact TuHURA Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises TuHURA Biosciences' investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2023-09-19 | 2023-06-30 | -36.92 | -68.25 | -31.33 | 84 | ||
2023-05-11 | 2023-03-31 | -6.65 | -67.9 | -61.25 | 921 |
TuHURA Biosciences' market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 141.65 M.Market Cap |
|
TuHURA Biosciences' profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (7.73) | (7.34) | |
| Return On Capital Employed | (44.72) | (42.48) | |
| Return On Assets | (7.73) | (7.34) | |
| Return On Equity | 16.93 | 17.77 |
Determining TuHURA Biosciences' profitability involves analyzing its financial statements and using various financial metrics to determine if TuHURA Biosciences is a good buy. For example, gross profit margin measures TuHURA Biosciences' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of TuHURA Biosciences' profitability and make more informed investment decisions.
Please note, the presentation of TuHURA Biosciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, TuHURA Biosciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of TuHURA Biosciences' management manipulating its earnings.
Basic technical analysis of TuHURA Stock
As of the 24th of March, TuHURA Biosciences has the risk adjusted performance of (0.01), and Variance of 84.38. TuHURA Biosciences technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the company's future prices.TuHURA Biosciences' insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific TuHURA Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on TuHURA Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases TuHURA Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Hoffman Robert E. over two weeks ago Acquisition by Hoffman Robert E. of 51275 shares of TuHURA Biosciences at 4.11 subject to Rule 16b-3 | ||
Ng George K over two months ago Acquisition by Ng George K of 51275 shares of TuHURA Biosciences at 4.11 subject to Rule 16b-3 | ||
Dearborn Dan over three months ago Acquisition by Dearborn Dan of 489848 shares of TuHURA Biosciences at 4.94 subject to Rule 16b-3 |
TuHURA Biosciences' Outstanding Corporate Bonds
TuHURA Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. TuHURA Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most TuHURA bonds can be classified according to their maturity, which is the date when TuHURA Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand TuHURA Biosciences' technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing TuHURA Biosciences' various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.26) | |||
| Mean Deviation | 6.64 | |||
| Coefficient Of Variation | (4,693) | |||
| Standard Deviation | 9.19 | |||
| Variance | 84.38 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | 0.4919 | |||
| Treynor Ratio | (0.27) | |||
| Maximum Drawdown | 33.6 | |||
| Value At Risk | (12.91) | |||
| Potential Upside | 15.7 | |||
| Skewness | 1.1 | |||
| Kurtosis | 3.29 |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.26) | |||
| Mean Deviation | 6.64 | |||
| Coefficient Of Variation | (4,693) | |||
| Standard Deviation | 9.19 | |||
| Variance | 84.38 | |||
| Information Ratio | (0.02) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | 0.4919 | |||
| Treynor Ratio | (0.27) | |||
| Maximum Drawdown | 33.6 | |||
| Value At Risk | (12.91) | |||
| Potential Upside | 15.7 | |||
| Skewness | 1.1 | |||
| Kurtosis | 3.29 |
Consider TuHURA Biosciences' intraday indicators
TuHURA Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of TuHURA Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
TuHURA Biosciences time-series forecasting models is one of many TuHURA Biosciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary TuHURA Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
TuHURA Stock media impact
Far too much social signal, news, headlines, and media speculation about TuHURA Biosciences that are available to investors today. That information is available publicly through TuHURA media outlets and privately through word of mouth or via TuHURA internal channels. However, regardless of the origin, that massive amount of TuHURA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of TuHURA Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of TuHURA Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to TuHURA Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive TuHURA Biosciences alpha.
TuHURA Biosciences Corporate Executives
Elected by the shareholders, the TuHURA Biosciences' board of directors comprises two types of representatives: TuHURA Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TuHURA. The board's role is to monitor TuHURA Biosciences' management team and ensure that shareholders' interests are well served. TuHURA Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TuHURA Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Patricia Lawman | CoFounder | Profile | |
| Michael Lawman | CoFounder | Profile | |
| Dan CPA | Executive CFO | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in TuHURA Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TuHURA Biosciences. If investors know TuHURA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TuHURA Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of TuHURA Biosciences is measured differently than its book value, which is the value of TuHURA that is recorded on the company's balance sheet. Investors also form their own opinion of TuHURA Biosciences' value that differs from its market value or its book value, called intrinsic value, which is TuHURA Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TuHURA Biosciences' market value can be influenced by many factors that don't directly affect TuHURA Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between TuHURA Biosciences' value and its price, as these two are different measures arrived at by various means. Investors typically determine if TuHURA Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TuHURA Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.